메뉴 건너뛰기




Volumn 76, Issue 3, 1997, Pages 306-311

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

Author keywords

Breast cancer; PAI 1; Prognosis; Protease; Steroid hormone receptor; Time variation; Urokinase; Urokinase type plasminogen activator

Indexed keywords

ESTROGEN RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE RECEPTOR; STEROID RECEPTOR; UROKINASE;

EID: 0030838482     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.383     Document Type: Article
Times cited : (64)

References (39)
  • 1
    • 0028179558 scopus 로고
    • Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors
    • Altman DG, Lausen B, Sauerbrei W and Schumacher M (1944) Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829-835
    • (1944) J Natl Cancer Inst , vol.86 , pp. 829-835
    • Altman, D.G.1    Lausen, B.2    Sauerbrei, W.3    Schumacher, M.4
  • 4
    • 0028309791 scopus 로고
    • Urokinase plasminogen activator (uPA) and its type I inhibitor (PAI-1): Regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer
    • Brünner N, Pyke C, Hansen CH, Romer J, Grøndahl-Hansen J and Danø K (1994) Urokinase plasminogen activator (uPA) and its type I inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer. Cancer Treat Res 71: 299-309
    • (1994) Cancer Treat Res , vol.71 , pp. 299-309
    • Brünner, N.1    Pyke, C.2    Hansen, C.H.3    Romer, J.4    Grøndahl-Hansen, J.5    Danø, K.6
  • 5
    • 0000336139 scopus 로고
    • Regression models and life-tables
    • Cox DR (1972) Regression models and life-tables. J R Stat Soc (B) 34: 187-200
    • (1972) J R Stat Soc (B) , vol.34 , pp. 187-200
    • Cox, D.R.1
  • 8
    • 0029065722 scopus 로고
    • Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
    • Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ and Duffy MJ (1995) Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer 61: 597-600
    • (1995) Int J Cancer , vol.61 , pp. 597-600
    • Duggan, C.1    Maguire, T.2    McDermott, E.3    O'Higgins, N.4    Fennelly, J.J.5    Duffy, M.J.6
  • 9
    • 0025336879 scopus 로고
    • The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
    • Estreicher A, Muhlhauser J, Carpentier JL, Orci L and Vassalli JD (1990) The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111: 783-792
    • (1990) J Cell Biol , vol.111 , pp. 783-792
    • Estreicher, A.1    Muhlhauser, J.2    Carpentier, J.L.3    Orci, L.4    Vassalli, J.D.5
  • 14
    • 21144472187 scopus 로고
    • Flexible methods for analyzing survival data using splines, with applications to breast cancer prognosis
    • Gray RJ (1992). Flexible methods for analyzing survival data using splines, with applications to breast cancer prognosis. J Am Stat Assoc 87: 942-951
    • (1992) J Am Stat Assoc , vol.87 , pp. 942-951
    • Gray, R.J.1
  • 15
    • 0027223048 scopus 로고
    • High levels of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis
    • Grøndahl-Hansen J, Christensen IJ, Rosenquist C, Rosenquist C, Brünner N, Mouridsen HT, Danø K and Blichert-Toft M (1993) High levels of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 53: 2513-2521
    • (1993) Cancer Res , vol.53 , pp. 2513-2521
    • Grøndahl-Hansen, J.1    Christensen, I.J.2    Rosenquist, C.3    Rosenquist, C.4    Brünner, N.5    Mouridsen, H.T.6    Danø, K.7    Blichert-Toft, M.8
  • 16
    • 0024576759 scopus 로고
    • Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder
    • Hasui Y, Suzumiya J, Marutsuka K, Sumiyoshi A, Hashida S and Ishikawa E (1989) Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder. Cancer Res 49: 1067-1070
    • (1989) Cancer Res , vol.49 , pp. 1067-1070
    • Hasui, Y.1    Suzumiya, J.2    Marutsuka, K.3    Sumiyoshi, A.4    Hashida, S.5    Ishikawa, E.6
  • 17
    • 0028885643 scopus 로고
    • Individual development and uPA-receptor expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer
    • Heiss MM, Allgayer H, Gruetzner KU, Funke I, Babic R, Jauch KW and Schildberg FW (1995) Individual development and uPA-receptor expression of disseminated tumor cells in bone marrow: A reference to early systemic disease in solid cancer. Nature Med 1: 1035-1039
    • (1995) Nature Med , vol.1 , pp. 1035-1039
    • Heiss, M.M.1    Allgayer, H.2    Gruetzner, K.U.3    Funke, I.4    Babic, R.5    Jauch, K.W.6    Schildberg, F.W.7
  • 18
    • 0029097254 scopus 로고
    • Tumor associated proteolysis and prognosis: New functional risk factors in gastric cancer defined by the urokinase type plasminogen activator system
    • Heiss MM, Babic R, Allgayer H, Gruetzner KU, Jauch KW, Loehrs U and Schildberg FW (1995) Tumor associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase type plasminogen activator system. J Clin Oncol 13: 2084-2093
    • (1995) J Clin Oncol , vol.13 , pp. 2084-2093
    • Heiss, M.M.1    Babic, R.2    Allgayer, H.3    Gruetzner, K.U.4    Jauch, K.W.5    Loehrs, U.6    Schildberg, F.W.7
  • 19
    • 0030061899 scopus 로고    scopus 로고
    • Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancer
    • Hofmann R, Lehmer A, Hartung R, Robrecht C, Buresch M and Grothe F (1996) Prognostic value of urokinase plasminogen activator and plasminogen activator inhibitor-1 in renal cell cancer. J Urol 155: 858-862
    • (1996) J Urol , vol.155 , pp. 858-862
    • Hofmann, R.1    Lehmer, A.2    Hartung, R.3    Robrecht, C.4    Buresch, M.5    Grothe, F.6
  • 20
    • 0028951043 scopus 로고
    • Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
    • Holmgren L, O'Reilly MS and Folkman J (1995) Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 2: 149-153
    • (1995) Nature Med , vol.2 , pp. 149-153
    • Holmgren, L.1    O'Reilly, M.S.2    Folkman, J.3
  • 21
    • 0028358771 scopus 로고
    • Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor plasminogen activator inhibitor type I
    • Jänicke F, Pache L, Schmitt M, Ulm K, Thomssen Ch, Prechtl A and Graeff H (1994) Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor plasminogen activator inhibitor type I. Cancer Res 54: 2527-2530
    • (1994) Cancer Res , vol.54 , pp. 2527-2530
    • Jänicke, F.1    Pache, L.2    Schmitt, M.3    Ulm, K.4    Thomssen, Ch.5    Prechtl, A.6    Graeff, H.7
  • 22
    • 0025995880 scopus 로고
    • Clinical relevance of the urokinase-type and the tissue-type plasminogen activators and of their inhibitor PAI-1 in breast cancer
    • Jänicke F, Schmitt M and Graeff H (1991) Clinical relevance of the urokinase-type and the tissue-type plasminogen activators and of their inhibitor PAI-1 in breast cancer. Semin Thromb Hemostas 17: 303-312
    • (1991) Semin Thromb Hemostas , vol.17 , pp. 303-312
    • Jänicke, F.1    Schmitt, M.2    Graeff, H.3
  • 24
    • 0027082979 scopus 로고
    • Urokinase (uPA) and its inhibitor PAI-1 are strong, independent prognostic factors in node-negative breast cancer
    • Jänicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Höfler H and Graeff H (1993) Urokinase (uPA) and its inhibitor PAI-1 are strong, independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195-208
    • (1993) Breast Cancer Res Treat , vol.24 , pp. 195-208
    • Jänicke, F.1    Schmitt, M.2    Pache, L.3    Ulm, K.4    Harbeck, N.5    Höfler, H.6    Graeff, H.7
  • 25
    • 0029873910 scopus 로고    scopus 로고
    • The urokinase receptor is a major vitronectin-binding protein on endothelial cells
    • Kanse S, Kost C, Wilhelm O, Andreasen PA and Preissner KT (1996) The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res 224: 344-353
    • (1996) Exp Cell Res , vol.224 , pp. 344-353
    • Kanse, S.1    Kost, C.2    Wilhelm, O.3    Andreasen, P.A.4    Preissner, K.T.5
  • 26
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL and Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 27
    • 0028639208 scopus 로고
    • Impact of urokinase type plasminogen activator and its inhibitor type I on prognosis in cervical cancer of the uterus
    • Kobayashi H, Fujishiro S and Terao T (1994) Impact of urokinase type plasminogen activator and its inhibitor type I on prognosis in cervical cancer of the uterus. Cancer Res 54: 6539-6548
    • (1994) Cancer Res , vol.54 , pp. 6539-6548
    • Kobayashi, H.1    Fujishiro, S.2    Terao, T.3
  • 28
    • 0028656476 scopus 로고
    • Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy
    • Kuhn W, Pache L, Schmalfeldt B, Dettmar P, Schmitt M, Jänicke F and Graeff H (1994) Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy. Gynecol Oncol 55: 401-409
    • (1994) Gynecol Oncol , vol.55 , pp. 401-409
    • Kuhn, W.1    Pache, L.2    Schmalfeldt, B.3    Dettmar, P.4    Schmitt, M.5    Jänicke, F.6    Graeff, H.7
  • 29
    • 0026720849 scopus 로고
    • The changing importance of prognostic factors in breast cancer during long-term follow-up
    • Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Marin S and Syrjanen K (1992) The changing importance of prognostic factors in breast cancer during long-term follow-up. Int J Cancer 51: 698-702
    • (1992) Int J Cancer , vol.51 , pp. 698-702
    • Lipponen, P.1    Aaltomaa, S.2    Eskelinen, M.3    Kosma, V.M.4    Marin, S.5    Syrjanen, K.6
  • 30
    • 0028900705 scopus 로고
    • Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells
    • Liu G, Shuman MA and Cohen RL (1995) Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer 60: 501-506
    • (1995) Int J Cancer , vol.60 , pp. 501-506
    • Liu, G.1    Shuman, M.A.2    Cohen, R.L.3
  • 32
    • 0028070859 scopus 로고
    • Prognostic impact of urokinase, urokinase receptor and type I plasminogen activator inhibitor in squamous and large cell lung cancer tissue
    • Pedersen H, Brünner N, Francis D, Osterlind K, Rønne E, Hansen HH, Danø K and Grondahl-Hansen J (1994) Prognostic impact of urokinase, urokinase receptor and type I plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 54: 4671-4675
    • (1994) Cancer Res , vol.54 , pp. 4671-4675
    • Pedersen, H.1    Brünner, N.2    Francis, D.3    Osterlind, K.4    Rønne, E.5    Hansen, H.H.6    Danø, K.7    Grondahl-Hansen, J.8
  • 33
  • 38
    • 0029834684 scopus 로고    scopus 로고
    • Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis
    • Xing RH and Rabbani SA (1996) Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis. Int J Cancer 67: 423-429
    • (1996) Int J Cancer , vol.67 , pp. 423-429
    • Xing, R.H.1    Rabbani, S.A.2
  • 39
    • 0027428678 scopus 로고
    • Time dependency of the influence of prognostic factors on relapse in breast cancer
    • Yoshimoto M, Sakamoto G and Ohashi Y (1993) Time dependency of the influence of prognostic factors on relapse in breast cancer. Cancer 10: 2993-3001
    • (1993) Cancer , vol.10 , pp. 2993-3001
    • Yoshimoto, M.1    Sakamoto, G.2    Ohashi, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.